Medical Image Analysis Software Market (Software Type - Integrated Software and Standalone Software; Imaging Type - 2D Imaging, 3D Imaging, and 4D Imaging; Modality - CT, MRI, PET, SPECT, Ultrasound, and Radiographic Imaging; Application: Cardiology, Orthopedic, Oncology, Neurology, Nephrology, Dental, and Gynecology; End Users - Hospital, Clinics, Research and Academic Institution, Diagnostic Centers, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2019 - 2030

The global medical image analysis software market for the historical period 2017–2018 and forecast period 2019–2027, increase in the incidence of chronic diseases, rise in geriatric population, increase in the adoption of 4D imaging techniques, and rise in demand for medical imaging are projected to drive the global medical image analysis software market during the forecast period

According to the report, the global medical image analysis software market was valued at US$ 2.91 Bn in 2018 and is anticipated to expand at a CAGR of 8.1% from 2019 to 2030

Increasing demand for medical imaging: Key Drivers

Medical imaging provides diagnosis of various diseases such as cancer, cardiovascular diseases, and neurological and gynecological disorders. Undergoing the medical imaging procedures such as CT, MRI, ultrasound, PET, and SPECT has various benefits such as early diagnosis of a disease, less need for surgery, fewer hospital admissions, and reduction in hospital stay.

In the emergency department, medical imaging has shortened the patient’s waiting time. According to American College of Radiology, the diagnostic imaging industry has expanded over a decade due to the population being covered under Medicare, particularly for expensive techniques such as CT, MRI, and PET.

According to NHS England, 39.8 million imaging tests were reported in England by the end of March 2017, as compared to 37.9 million imaging tests by the end of March 2014. Among these, 22.6 million tests were radiography, 8.57 million were ultrasound, 4.20 million were CT, and 2.89 million were MRI scan.

The increasing demand for medical imaging is likely to boost the medical imaging analysis software market during the forecast period.

Increasing Incidence of Chronic Diseases such as Cancer and Cardiovascular Diseases Boost Market Growth

Cancer is a serious health problem affecting large population across the globe. Diagnosis at an early stage and treatment for cancer when it affects the immune system pose a challenge for health care service providers. According to WHO, in 2017, there were 14 million new cases of cancer and approximately 8.2 million deaths caused by cancer every year. Around 70% rise in the number of cancer cases across the globe is expected in the decade, with 60% of these cases from Africa, Asia, and Latin America.

Cardiovascular diseases are also highly prevalent across the globe and is a major cause of deaths in developed countries. Increasing incidence of obesity, changing lifestyles of people, and their unhealthy eating habits lead to increase in the incidence of cardiovascular diseases. According to WHO, 17.5 million people die of cardiovascular diseases every year, which accounts for 31% of the total deaths.

Thus, increasing incidence of cancer and cardiovascular diseases would boost the CT and MRI imaging market which will in turn drive the software market during the forecast period

High Cost Associated With Medical Imaging Procedures to Hamper Market

Medical imaging has become an essential test for diagnosis of diseases and also, before the surgery.

The cost associated with medical imaging is very high; for instance, the average cost of MRI scan is US$ 400 – US$ 3,500, CT scan is US$ 1200, ultrasound is US$ 200 – US$ 1,000, PET scan is US$ 3,000 – US$ 20,000, and SPECT scan is US$ 3,500. With the increasing number of diseases, requirement for undergoing diagnostic procedures at every stage of a disease is high.

High cost associated with imaging techniques and the medication becomes a hindrance to several people that belong to the middle-income group.

Due to the cost associated with medical imaging and treatment, the people in low-income countries, who are not covered under medical insurance, hesitate to avail medical services. This causes a major hindrance for growth of the medical imaging analysis software market.

Global Medical Image Analysis Software Market: Competitive Landscape

This report profiles major players in the global medical image analysis software market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Leading players operating in the global medical image analysis software market are

• GE Healthcare
• Siemens Healthineers
• Agfa-Gevaert N.V.
• Hologic Inc.
• Pie Medical Imaging
• Media Cybernetics, Inc.
• AQUILAB
• MIM Software Inc
• Merge Healthcare Incorporated.
• ScienceSoft USA Corporation

Key Questions Answered in Global Medical Image Analysis Software Market Report

• What is the scope of growth of companies in the global medical image analysis software market?
• What will be the Y-o-Y growth of the global medical image analysis software market between 2019 and 2027?
• What is the influence of changing trends in technologies on the global medical image analysis software market?
• Will North America continue to be the most profitable market for medical image analysis software providers?
• Which factors are anticipated to hamper the growth of the global medical image analysis software market during the forecast period?
• Which are the leading companies in the global medical image analysis software market?

Global Medical Image Analysis Software Market – Segmentation

Software Type

• Integrated software type
• Standalone software type

Imaging Type

• 2D imaging
• 3D imaging
• 4D imaging

Modality

• CT
• MRI
• PET
• SPECT
• Ultrasound
• Radiographic imaging
• Other modalities

Application

• Cardiology
• Orthopaedic
• Oncology
• Neurology
• Nephrology
• Dental
• Gynaecology
• Others

End-user

• Hospitals
• Clinics
• Research and Academic Institutes
• Diagnostic Centers
• Ambulatory Surgical Centers (ASCs)

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Medical Image Analysis Software Market

4. Market Overview

    4.1. Introduction

        4.1.1. Software Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Medical Image Analysis Software Market Analysis and Forecasts, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Key Mergers & Acquisitions 

    5.2. Technological Advancements

6. Global Medical Image Analysis Software Market Analysis and Forecasts, by Software Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast by Software Type, 2017–2027

        6.3.1. Integrated software type

        6.3.2. Standalone software type

    6.4. Market Attractiveness by Software Type 

7. Global Medical Image Analysis Software Market Analysis and Forecasts, by Imaging Type 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast by Imaging Type, 2017–2027

        7.3.1. 2D imaging 

        7.3.2. 3D imaging 

        7.3.3. 4D imaging 

    7.4. Market Attractiveness by Imaging Type 

8. Global Medical Image Analysis Software Market Analysis and Forecasts, by Modality 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast by Modality, 2017–2027

        8.3.1. CT

        8.3.2. MRI

        8.3.3. PET

        8.3.4. SPECT

        8.3.5. Ultrasound

        8.3.6. Radiographic imaging 

        8.3.7. Other modalities 

    8.4. Market Attractiveness by Modality 

9. Global Medical Image Analysis Software Market Analysis and Forecasts, by Application 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast by Application, 2017–2027

        9.3.1. Cardiology

        9.3.2. Orthopaedic

        9.3.3. Oncology

        9.3.4. Neurology 

        9.3.5. Nephrology 

        9.3.6. Dental

        9.3.7. Gynaecology 

        9.3.8. Others

    9.4. Market Attractiveness by Application 

10. Global Medical Image Analysis Software Market Analysis and Forecasts, by End-user 

    10.1. Introduction & Definition

    10.2. Key Findings / Developments

    10.3. Market Value Forecast by End-user, 2017–2027

        10.3.1. Hospitals

        10.3.2. Clinics

        10.3.3. Research and Academic Institutes

        10.3.4. Diagnostic Centers

        10.3.5. Ambulatory Surgical Centers (ASCs)

    10.4. Market Attractiveness by End-user 

11. Global Medical Image Analysis Software Market Analysis and Forecasts, by Region

    11.1. Key Findings

    11.2. Market Value Forecast by Region

        11.2.1. North America 

        11.2.2. Europe 

        11.2.3. Asia Pacific 

        11.2.4. Latin America 

        11.2.5. Middle East & Africa 

    11.3. Market Attractiveness by Country/Region

12. North America Medical Image Analysis Software Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast by Software Type, 2017–2027

        12.2.1. Integrated software type

        12.2.2. Standalone software type

    12.3. Market Value Forecast by Imaging Type, 2017–2027

        12.3.1. 2D imaging 

        12.3.2. 3D imaging 

        12.3.3. 4D imaging 

    12.4. Market Value Forecast by Modality, 2017–2027

        12.4.1. CT

        12.4.2. MRI

        12.4.3. PET

        12.4.4. SPECT

        12.4.5. Ultrasound

        12.4.6. Radiographic imaging 

        12.4.7. Other modalities 

    12.5. Market Value Forecast by Application, 2017–2027

        12.5.1. Cardiology

        12.5.2. Orthopaedic

        12.5.3. Oncology

        12.5.4. Neurology 

        12.5.5. Nephrology 

        12.5.6. Dental

        12.5.7. Gynaecology 

        12.5.8. Others

    12.6. Market Value Forecast by End-user, 2017–2027

        12.6.1. Hospitals

        12.6.2. Clinics

        12.6.3. Research and Academic Institutes

        12.6.4. Diagnostic Centers

        12.6.5. Ambulatory Surgical Centers (ASCs)

    12.7. Market Value Forecast by Country, 2017–2027

        12.7.1. U.S.

        12.7.2. Canada

    12.8. Market Attractiveness Analysis 

        12.8.1. By Software Type 

        12.8.2. By Imaging Type 

        12.8.3. By Modality 

        12.8.4. By Application 

        12.8.5. By End-user 

        12.8.6. By Country

13. Europe Medical Image Analysis Software Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast by Software Type, 2017–2027

        13.2.1. Integrated software type

        13.2.2. Standalone software type

    13.3. Market Value Forecast by Imaging Type, 2017–2027

        13.3.1. 2D imaging 

        13.3.2. 3D imaging 

        13.3.3. 4D imaging 

    13.4. Market Value Forecast by Modality, 2017–2027

        13.4.1. CT

        13.4.2. MRI

        13.4.3. PET

        13.4.4. SPECT

        13.4.5. Ultrasound

        13.4.6. Radiographic imaging 

        13.4.7. Other modalities 

    13.5. Market Value Forecast by Application, 2017–2027

        13.5.1. Cardiology

        13.5.2. Orthopaedic

        13.5.3. Oncology

        13.5.4. Neurology 

        13.5.5. Nephrology 

        13.5.6. Dental

        13.5.7. Gynaecology 

        13.5.8. Others

    13.6. Market Value Forecast by End-user, 2017–2027

        13.6.1. Hospitals

        13.6.2. Clinics

        13.6.3. Research and Academic Institutes

        13.6.4. Diagnostic Centers

        13.6.5. Ambulatory Surgical Centers (ASCs)

    13.7. Market Value Forecast by Country,/Sub-region, 2017–2027

        13.7.1. Germany

        13.7.2. U.K.

        13.7.3. France

        13.7.4. Italy

        13.7.5. Spain

        13.7.6. Rest of Europe

    13.8. Market Attractiveness Analysis 

        13.8.1. By Software Type 

        13.8.2. By Imaging Type 

        13.8.3. By Modality 

        13.8.4. By Application 

        13.8.5. By End-user 

        13.8.6. By Country,/Sub-region

14. Asia Pacific Medical Image Analysis Software Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast by Software Type, 2017–2027

        14.2.1. Integrated software type

        14.2.2. Standalone software type

    14.3. Market Value Forecast by Imaging Type, 2017–2027

        14.3.1. 2D imaging 

        14.3.2. 3D imaging 

        14.3.3. 4D imaging 

    14.4. Market Value Forecast by Modality, 2017–2027

        14.4.1. CT

        14.4.2. MRI

        14.4.3. PET

        14.4.4. SPECT

        14.4.5. Ultrasound

        14.4.6. Radiographic imaging 

        14.4.7. Other modalities 

    14.5. Market Value Forecast by Application, 2017–2027

        14.5.1. Cardiology

        14.5.2. Orthopaedic

        14.5.3. Oncology

        14.5.4. Neurology 

        14.5.5. Nephrology 

        14.5.6. Dental

        14.5.7. Gynaecology 

        14.5.8. Others

    14.6. Market Value Forecast by End-user, 2017–2027

        14.6.1. Hospitals

        14.6.2. Clinics

        14.6.3. Research and Academic Institutes

        14.6.4. Diagnostic Centers

        14.6.5. Ambulatory Surgical Centers (ASCs)

    14.7. Market Value Forecast by Country,/Sub-region, 2017–2027

        14.7.1. China

        14.7.2. India

        14.7.3. Japan

        14.7.4. Australia & New Zealand

        14.7.5. Rest of Asia Pacific

    14.8. Market Attractiveness Analysis 

        14.8.1. By Software Type 

        14.8.2. By Imaging Type 

        14.8.3. By Modality 

        14.8.4. By Application 

        14.8.5. By End-user 

        14.8.6. By Country,/Sub-region

15. Latin America Medical Image Analysis Software Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast by Software Type, 2017–2027

        15.2.1. Integrated software type

        15.2.2. Standalone software type

    15.3. Market Value Forecast by Imaging Type, 2017–2027

        15.3.1. 2D imaging 

        15.3.2. 3D imaging 

        15.3.3. 4D imaging 

    15.4. Market Value Forecast by Modality, 2017–2027

        15.4.1. CT

        15.4.2. MRI

        15.4.3. PET

        15.4.4. SPECT

        15.4.5. Ultrasound

        15.4.6. Radiographic imaging 

        15.4.7. Other modalities 

    15.5. Market Value Forecast by Application, 2017–2027

        15.5.1. Cardiology

        15.5.2. Orthopaedic

        15.5.3. Oncology

        15.5.4. Neurology 

        15.5.5. Nephrology 

        15.5.6. Dental

        15.5.7. Gynaecology 

        15.5.8. Others

    15.6. Market Value Forecast by End-user, 2017–2027

        15.6.1. Hospitals

        15.6.2. Clinics

        15.6.3. Research and Academic Institutes

        15.6.4. Diagnostic Centers

        15.6.5. Ambulatory Surgical Centers (ASCs)

    15.7. Market Value Forecast by Country,/Sub-region, 2017–2027

        15.7.1. Brazil

        15.7.2. Mexico

        15.7.3. Rest of Latin America

    15.8. Market Attractiveness Analysis 

        15.8.1. By Software Type 

        15.8.2. By Imaging Type 

        15.8.3. By Modality 

        15.8.4. By Application 

        15.8.5. By End-user 

        15.8.6. By Country,/Sub-region

16. Middle East & Africa Medical Image Analysis Software Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Market Value Forecast by Software Type, 2017–2027

        16.2.1. Integrated software type

        16.2.2. Standalone software type

    16.3. Market Value Forecast by Imaging Type, 2017–2027

        16.3.1. 2D imaging 

        16.3.2. 3D imaging 

        16.3.3. 4D imaging 

    16.4. Market Value Forecast by Modality, 2017–2027

        16.4.1. CT

        16.4.2. MRI

        16.4.3. PET

        16.4.4. SPECT

        16.4.5. Ultrasound

        16.4.6. Radiographic imaging 

        16.4.7. Other modalities 

    16.5. Market Value Forecast by Application, 2017–2027

        16.5.1. Cardiology

        16.5.2. Orthopaedic

        16.5.3. Oncology

        16.5.4. Neurology 

        16.5.5. Nephrology 

        16.5.6. Dental

        16.5.7. Gynaecology 

        16.5.8. Others

    16.6. Market Value Forecast by End-user, 2017–2027

        16.6.1. Hospitals

        16.6.2. Clinics

        16.6.3. Research and Academic Institutes

        16.6.4. Diagnostic Centers

        16.6.5. Ambulatory Surgical Centers (ASCs)

    16.7. Market Value Forecast by Country,/Sub-region, 2017–2027

        16.7.1. GCC Countries

        16.7.2. South Africa

        16.7.3. Rest of Middle East & Africa

    16.8. Market Attractiveness Analysis 

        16.8.1. By Software Type 

        16.8.2. By Imaging Type 

        16.8.3. By Modality 

        16.8.4. By Application 

        16.8.5. By End-user 

        16.8.6. By Country,/Sub-region

17. Competition Landscape

    17.1. Market Player – Competition Matrix (by Tier and Size of companies)

    17.2. Market Share Analysis by Company (2018)

    17.3. Company Profiles

        17.3.1. GE Healthcare 

            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.1.2. Growth Strategies

            17.3.1.3. SWOT Analysis

        17.3.2. Siemens Healthineers 

            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.2.2. Growth Strategies

            17.3.2.3. SWOT Analysis

        17.3.3. Agfa-Gevaert N.V. 

            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.3.2. Growth Strategies

            17.3.3.3. SWOT Analysis

        17.3.4. Hologic Inc. 

            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.4.2. Growth Strategies

            17.3.4.3. SWOT Analysis

        17.3.5. Pie Medical Imaging 

            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.5.2. Growth Strategies

            17.3.5.3. SWOT Analysis

        17.3.6. Media Cybernetics, Inc. 

            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.6.2. Growth Strategies

            17.3.6.3. SWOT Analysis

        17.3.7. AQUILAB

            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.7.2. Growth Strategies

            17.3.7.3. SWOT Analysis

        17.3.8. MIM Software Inc.

            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.8.2. Growth Strategies

            17.3.8.3. SWOT Analysis

        17.3.9. Merge Healthcare Incorporated

            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.9.2. Growth Strategies

            17.3.9.3. SWOT Analysis

        17.3.10. ScienceSoft USA Corporation

            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.10.2. Growth Strategies

            17.3.10.3. SWOT Analysis